Member Info for tuan6

Because Vlad thinks 25 discount on place new share too expensive so he choose 10 % from Mint . this 10% have a weapon kill off value share death than place share with 25 less for one time. next time carefully with CLN when the share we dont know and they can destroy so quitch. at the moment there is no way escape Mint to convert share .Hemo have their money now is their turn . If Vlad can make a deal and have money pay them off with 10 % interest so we are safe but not now.

Hemo need to pay back ORGS 2 millions so how do they do it dont know yes , there is no mention on that money either but they will pay back .

they said can earn 12% from mice but that all they said no real number for how much mice can earn from last year final. all the thing will turn back real is blood research and new one is CAR T ,but the main still CDX , all other put it in the past as record only .

you are correct. Hemo from form company until now dont have any real IP offer and from project to other project. daring covid they turn into covid and breakthrough research but nothing come out. after that it come out CAR T while CDX is not finish yes, there are co-op with J$J too and no report whatever result too . the question is what is really Hemo doing now? why they abandons all other research including covid and co op with J&J and now concertate on CDX then CART T

no . all of his post not come true in any sense . said it a lot but none of them come out true and he is very positive. I don't value his post many time until now . he post like as inside Infor but it turn out not true as yesterday he said a interview but nothing at all . how can it should be if Hemo want to make a interview people should know it now but as he posted that from yesterday.

Here is CLN worth 60 millions share conversion so as soon as pay off CLN it will be ok but until Hemo have an income the road will bum over many times.
https://www.lse.co.uk/rns/HEMO/financing-facility-of-up-to-16360-million-reb6rf302666t8j.html

The CLN is death end , as soon as share is up Mint will try to convert is share so they will more shares to sell to market. MMS need some one buy all that shares or they will drop it that is normal supply and demand .The deal end news have show off and in the mean time there is no other news people is waiting too.

Mint have left 9.5 millions share convert so they will play hard on share price .they dont care how bad it is , it is sure they can sell whatever price on that day and can convert share with 10 less so there is no harm to Mint but very bad to Hemo share holder as we have more share dilution market.

The number is 6 billions share can convert to it as Hemo public not long ago so there is only hope some how they can have deal with GC and pay off CLN as fast as it can . the longer it hold on CLN the bad it will get .

When I ask him over tweeted he asked only need RNS when there is some Infor need update but don't RNS as share holder hope to see. He is good at his processional job but he is not a good men on media and if you followed his tweeted there are many people see it quite confuse and shouldn't do that if he is a CEO of company.

some people have been losing money if just jump in as if reading his tweeted and believer the deal but he know in advance if there is more job to do to get its destination so just keeping it quite as it going so people don't expecting too much .

Hemo have only 12 millions cash at the moment but they need conver to share and Mint just do as far as 2.5millions so there are more 9.5 millions value into share conversion . At the CAP now it is too low for it work out .they can't do over 3% each conversation but if they do many time and share will be less value so losing it all .

If Mint cant convert 9.5 million left because it is too low maybe they will cancel the 48 millions so there is no guarantee Hemo have 60 millions in the bank.

Mint lend money to Hemo so they need to get it back with interest that is natural .

Only when the trial and GC pay Hemo so the CLN will pay off and we see the light but now is the dark as nothing is really can bargain with GC to ask them pay Hemo some money now. They are not interested with pre trial drug and wit small company too. They want big and can turn into profit now

There is degree of risk with new drug . Nobody can sure it work for first time so simple GC leave that job for Hemo do it and caring the risk and reward. After the first trial and data come out is good and have second go they will stay and talk about money . Now all the risk move to Hemo and the big pharma dont care it at all .

Hemo use IP and comfident data from GC so they will share benefit if everything work out . If the first not work they need more time to correct it and try again .

The job is from start a news drug and GC didnot see its benifit now to turn money on shor tern . If nothing work Hemo will go other try and GC just smile for nothing concern.

It will depend in how drug work out first. Without any first trial we cant say anything on how hight this share is . They said 20 or 30 is only dream . Nothing is certain and there is no base on that number either. Just a igame number for fun now.

The trouble until now there is no production offer now. that is why share is down . only they bring out test kit will lift share if they can do this end of this month. wait and see .

From Feb. this year all RNS out is director option or sell share . So bad for public if the director work for company and destroy it .

The one thing is why it take very long for them to manufacturing test as they said end of this month with delivery 2 millions test kit but today there is no rns say they start the production line or whatever to make it. how can from now to the end they got 2 millions anyway? outsource to china and rebrand to ODX maybe?

We believe in ODX but we need more evident to show us how business is going on and how to keep up with . without any rns on how they can delivery this kind of business need carefully attention.

There is little help at the moment , no more news we are expecting have at least months and only CAR T is main hope now. all of the other project is on hold and no update at all. the money Hemo draw 12 million in their bank band plant to do all work so from now then we will see more Mint convert share RNS than before. there will be heavy dilution on shares next year .

All hope on CDX is finish as we know. it didnot death end but there is no more financial help from outside at all . Hemo must find itself to do all that work themselves and if they can pass the first phase 1 , this will bring huge value for hemo ,If it cant pass the first we will gone with the win.

It cant be sure they will certainly pass the first phase 1.let put it through the trial first and the result come back will tell us how it perform. At the moment nothing guaranty .we hope they will success

It is the end we are all after money so as soon as people sell it off and we will forget who is Hemo. People in here bought and sold many different shares and if you can recall only some remember but basic forget everything.

It is only show that CDX is less value and they dont invest .They can pay billion if it show work and can turn into profit.As long as Hemo can show it work they will consider later. Nothing is worth in CDX at the moment
.it only value when finish trial and the cost Hemo pay the cost.

Why does it take long time and the cooperation is continuing ? It is simple Hemo use IP and confidential technical from them to create CDX . That is why they will share % eath other when licensing it to thiry party or GC pay Hemo to owe CDX.

Drug on paper untill it show how it works for human take long time . It is not month but years. The better it is the more value it get but for now there is nothing value at all.

All of other co-op from Hemo with other institutions on research untill now no update or nothing show up.let to ask a question when should they update or do they close that shouls shareholder have infom .

One thing for sure Hemo did not delivery any positive on covid research they said on last to now keep silent. After place shares at 7p all other only on CDX and CART so play covid for share place that is how this company need cash to run.

On CDX this is both Hemo and GC share the same benefit so they cant dump it away but need to go untill finish . Who know how they will share % each ?

The only real one is CAR T from this year but they need a lot money to do that . 60 millions is nothing to go alone . they need someone big to pay for them go or this will going crazy .

Yes if you believed in Pumpky and bought Reat at that time 6 months ago at 1p now you can sell 2.3p for over 100 % gain as smile. Something is too good to be true maybe is not good at all . a lot people smile at Reat and now just see how share perform over 6 months and look back . one thing for sure nothing is certain and the more it look good the more we need carefully thinking twin before commit all money on.

Thry updated covid with something called CRB and to do with cell and cute cancer too. Too much to ask and covid is gone with place shares at 7p from last year. I don't think anything with covid work now but on CDX and CAR T only.

Somebody in here said that billionaire invested and that nick still in here. I dont want to point out but that is true said and it past now. Forget it and going on .

Covud project is gone and something come out CRB Nobody know how it work. Covid short this share from nothing to 14 and now come back as normal.

Now is the real thing and if they can bring out something sellable or it will take longer to earn some money .

Sometimes ago someone in here said a Canadian billionaire invested in Hemo with Mint fund but that is make up story and now it show off their true face. The thing Mint do only for their money .
Who did say billionaire invested in Hemo should go out with something to say they create this for their benifit not for chatter in here.

GC and Hemo share the research and GC fund the whole thing. That is why they didn't go away long time. If they go Hemo must pay back all IP and fund of all work untill now.

They will go untill trial and decide how to share this work and what% each party will get if they sell IP to other party. If GC take all they will pay Hemo some money but the price is not what CEO like to accept so both sides will go on working until it trial .

Let remember Hemo only have part if the whole work and GC owe half so if smallest boy ask too much they will kick his ass as we see. Very poor on businesses when get something small than have nothing at all.

As people can see if Hemo have some money .we can pay off Mint plus 10% interest and the story is different. There is no more share convert and no more hard time RNS as we enter the phase when RNS monthly on convert shares.

Now only fund to do the trial work depend on Mint'money and there is no way to get rich of them as Hemo dont have any other income .Human trials must go on and more money need short term .

Let waiting and leave it more time when they come back with something saleable but now there is nothing for sell yes.